3.2.0.727 html 187 318 1 true 66 0 false 9 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.kitepharma.com/20150630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.kitepharma.com/20150630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETS CONDENSED CONSOLIDATED BALANCE SHEETS Statements 2 false false R3.htm 100020 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.kitepharma.com/20150630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Sheet http://www.kitepharma.com/20150630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) Statements 4 false false R5.htm 100040 - Statement - CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Sheet http://www.kitepharma.com/20150630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTOFCHANGESINSTOCKHOLDERSEQUITYUnaudited CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) Statements 5 false false R6.htm 100050 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Sheet http://www.kitepharma.com/20150630/taxonomy/role/StatementCONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWSUnaudited CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) Statements 6 false false R7.htm 100060 - Disclosure - BUSINESS AND NATURE OF OPERATIONS Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureBUSINESSANDNATUREOFOPERATIONS BUSINESS AND NATURE OF OPERATIONS Notes 7 false false R8.htm 100070 - Disclosure - BASIS OF PRESENTATION AND MANAGEMENT PLANS Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureBASISOFPRESENTATIONANDMANAGEMENTPLANS BASIS OF PRESENTATION AND MANAGEMENT PLANS Notes 8 false false R9.htm 100080 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSIGNIFICANTACCOUNTINGPOLICIES SIGNIFICANT ACCOUNTING POLICIES Notes 9 false false R10.htm 100090 - Disclosure - FAIR VALUE MEASUREMENTS AND INVESTMENTS IN MARKETABLE SECURITIES Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureFAIRVALUEMEASUREMENTSANDINVESTMENTSINMARKETABLESECURITIES FAIR VALUE MEASUREMENTS AND INVESTMENTS IN MARKETABLE SECURITIES Notes 10 false false R11.htm 100100 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosurePROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT Notes 11 false false R12.htm 100110 - Disclosure - LICENSE AND COLLABORATION AGREEMENTS Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureLICENSEANDCOLLABORATIONAGREEMENTS LICENSE AND COLLABORATION AGREEMENTS Notes 12 false false R13.htm 100120 - Disclosure - CONVERTIBLE NOTES PAYABLE Notes http://www.kitepharma.com/20150630/taxonomy/role/DisclosureCONVERTIBLENOTESPAYABLE CONVERTIBLE NOTES PAYABLE Notes 13 false false R14.htm 100130 - Disclosure - STOCKHOLDERS' EQUITY Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSTOCKHOLDERSEQUITY STOCKHOLDERS' EQUITY Notes 14 false false R15.htm 100140 - Disclosure - STOCK BASED COMPENSATION Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSTOCKBASEDCOMPENSATION STOCK BASED COMPENSATION Notes 15 false false R16.htm 100150 - Disclosure - INCOME TAXES Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureINCOMETAXES INCOME TAXES Notes 16 false false R17.htm 100160 - Disclosure - RELATED PARTIES Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureRELATEDPARTIES RELATED PARTIES Notes 17 false false R18.htm 100170 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureCOMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 18 false false R19.htm 100180 - Disclosure - T-CELL FACTORY ACQUISITION Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureTCELLFACTORYACQUISITION T-CELL FACTORY ACQUISITION Notes 19 false false R20.htm 100190 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSIGNIFICANTACCOUNTINGPOLICIESPolicies SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 20 false false R21.htm 100200 - Disclosure - SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSIGNIFICANTACCOUNTINGPOLICIESTables SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSIGNIFICANTACCOUNTINGPOLICIES 21 false false R22.htm 100210 - Disclosure - FAIR VALUE MEASUREMENTS AND INVESTMENTS IN MARKETABLE SECURITIES (Tables) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureFAIRVALUEMEASUREMENTSANDINVESTMENTSINMARKETABLESECURITIESTables FAIR VALUE MEASUREMENTS AND INVESTMENTS IN MARKETABLE SECURITIES (Tables) Tables http://www.kitepharma.com/20150630/taxonomy/role/DisclosureFAIRVALUEMEASUREMENTSANDINVESTMENTSINMARKETABLESECURITIES 22 false false R23.htm 100220 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosurePROPERTYANDEQUIPMENTTables PROPERTY AND EQUIPMENT (Tables) Tables http://www.kitepharma.com/20150630/taxonomy/role/DisclosurePROPERTYANDEQUIPMENT 23 false false R24.htm 100230 - Disclosure - STOCK BASED COMPENSATION (Tables) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSTOCKBASEDCOMPENSATIONTables STOCK BASED COMPENSATION (Tables) Tables http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSTOCKBASEDCOMPENSATION 24 false false R25.htm 100240 - Disclosure - T-CELL FACTORY ACQUISITION (Tables) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureTCELLFACTORYACQUISITIONTables T-CELL FACTORY ACQUISITION (Tables) Tables http://www.kitepharma.com/20150630/taxonomy/role/DisclosureTCELLFACTORYACQUISITION 25 false false R26.htm 100250 - Disclosure - Business and Nature of Operations - Additional Information (Details) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureBusinessAndNatureOfOperationsAdditionalInformationDetails Business and Nature of Operations - Additional Information (Details) Details 26 false false R27.htm 100260 - Disclosure - Basis of Presentation and Management Plans - Additional Information (Details) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureBasisOfPresentationAndManagementPlansAdditionalInformationDetails Basis of Presentation and Management Plans - Additional Information (Details) Details 27 false false R28.htm 100270 - Disclosure - Significant Accounting Policies - Additional Information (Details) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSignificantAccountingPoliciesAdditionalInformationDetails Significant Accounting Policies - Additional Information (Details) Details 28 false false R29.htm 100280 - Disclosure - Significant Accounting Policies - Summary of Accrued Expenses and Other Current Liabilities (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfAccruedExpensesAndOtherCurrentLiabilitiesDetail Significant Accounting Policies - Summary of Accrued Expenses and Other Current Liabilities (Detail) Details 29 false false R30.htm 100290 - Disclosure - Significant Accounting Policies - Summary of Potentially Dilutive Securities (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfPotentiallyDilutiveSecuritiesDetail Significant Accounting Policies - Summary of Potentially Dilutive Securities (Detail) Details 30 false false R31.htm 100300 - Disclosure - Significant Accounting Policies - Summary of Securities Excluded from the Computation of Potentially Dilutive Securities (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSignificantAccountingPoliciesSummaryOfSecuritiesExcludedFromComputationOfPotentiallyDilutiveSecuritiesDetail Significant Accounting Policies - Summary of Securities Excluded from the Computation of Potentially Dilutive Securities (Detail) Details 31 false false R32.htm 100310 - Disclosure - Significant Accounting Policies - Schedule of Summary of Calculation of Basic and Diluted Net Loss Per Common Share (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureSignificantAccountingPoliciesScheduleOfSummaryOfCalculationOfBasicAndDilutedNetLossPerCommonShareDetail Significant Accounting Policies - Schedule of Summary of Calculation of Basic and Diluted Net Loss Per Common Share (Detail) Details 32 false false R33.htm 100320 - Disclosure - Fair Value Measurements and Investments in Marketable Securities - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureFairValueMeasurementsAndInvestmentsInMarketableSecuritiesSummaryOfAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetail Fair Value Measurements and Investments in Marketable Securities - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) Details 33 false false R34.htm 100330 - Disclosure - Fair Value Measurements and Investments in Marketable Securities - Available-for-sale Securities (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureFairValueMeasurementsAndInvestmentsInMarketableSecuritiesAvailableForSaleSecuritiesDetail Fair Value Measurements and Investments in Marketable Securities - Available-for-sale Securities (Detail) Details 34 false false R35.htm 100340 - Disclosure - Fair Value Measurements and Investments in Marketable Securities - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureFairValueMeasurementsAndInvestmentsInMarketableSecuritiesAdditionalInformationDetail Fair Value Measurements and Investments in Marketable Securities - Additional Information (Detail) Details 35 false false R36.htm 100350 - Disclosure - Property and Equipment - Summary of Property and Equipment (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosurePropertyAndEquipmentSummaryOfPropertyAndEquipmentDetail Property and Equipment - Summary of Property and Equipment (Detail) Details 36 false false R37.htm 100360 - Disclosure - Property and Equipment - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosurePropertyAndEquipmentAdditionalInformationDetail Property and Equipment - Additional Information (Detail) Details 37 false false R38.htm 100370 - Disclosure - License and Collaboration Agreements - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsAdditionalInformationDetail License and Collaboration Agreements - Additional Information (Detail) Details 38 false false R39.htm 100380 - Disclosure - Convertible Notes Payable - Additional Information (Detail) Notes http://www.kitepharma.com/20150630/taxonomy/role/DisclosureConvertibleNotesPayableAdditionalInformationDetail Convertible Notes Payable - Additional Information (Detail) Details 39 false false R40.htm 100390 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 40 false false R41.htm 100400 - Disclosure - Stock Based Compensation - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformationDetail Stock Based Compensation - Additional Information (Detail) Details 41 false false R42.htm 100410 - Disclosure - Stock Based Compensation - Summary of Options Issued Under the Plan (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfOptionsIssuedUnderPlanDetail Stock Based Compensation - Summary of Options Issued Under the Plan (Detail) Details 42 false false R43.htm 100420 - Disclosure - Stock Based Compensation - Schedule of Black-Scholes Option Pricing Model (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfBlackScholesOptionPricingModelDetail Stock Based Compensation - Schedule of Black-Scholes Option Pricing Model (Detail) Details 43 false false R44.htm 100430 - Disclosure - Stock Based Compensation - Summary of Stock Based Compensation (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockBasedCompensationDetail Stock Based Compensation - Summary of Stock Based Compensation (Detail) Details 44 false false R45.htm 100440 - Disclosure - Stock Based Compensation- Schedule of Stock Options Outstanding (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureStockBasedCompensationScheduleOfStockOptionsOutstandingDetail Stock Based Compensation- Schedule of Stock Options Outstanding (Detail) Details 45 false false R46.htm 100450 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 46 false false R47.htm 100460 - Disclosure - Related Parties - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureRelatedPartiesAdditionalInformationDetail Related Parties - Additional Information (Detail) Details 47 false false R48.htm 100470 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 48 false false R49.htm 100480 - Disclosure - T-Cell Factory Acquisition - Additional Information (Details) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureTCellFactoryAcquisitionAdditionalInformationDetails T-Cell Factory Acquisition - Additional Information (Details) Details 49 false false R50.htm 100490 - Disclosure - T-Cell Factory Acquisition - Schedule of Calculation of Purchase Price (Details) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureTCellFactoryAcquisitionScheduleOfCalculationOfPurchasePriceDetails T-Cell Factory Acquisition - Schedule of Calculation of Purchase Price (Details) Details 50 false false R51.htm 100500 - Disclosure - T-Cell Factory Acquisition - Summary of Fair Value of Tangible and Intangible Assets Acquired and Liabilities Assumed (Details) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureTCellFactoryAcquisitionSummaryOfFairValueOfTangibleAndIntangibleAssetsAcquiredAndLiabilitiesAssumedDetails T-Cell Factory Acquisition - Summary of Fair Value of Tangible and Intangible Assets Acquired and Liabilities Assumed (Details) Details 51 false false R52.htm 100510 - Disclosure - T-Cell Factory Acquisition - Summary of Amortizable Intangible Assets Acquired With Respective Amortization Periods (Details) Sheet http://www.kitepharma.com/20150630/taxonomy/role/DisclosureTCellFactoryAcquisitionSummaryOfAmortizableIntangibleAssetsAcquiredWithRespectiveAmortizationPeriodsDetails T-Cell Factory Acquisition - Summary of Amortizable Intangible Assets Acquired With Respective Amortization Periods (Details) Details 52 false false R9999.htm Uncategorized Items - kite-20150630.xml Sheet http://xbrl.sec.gov/role/uncategorizedFacts Uncategorized Items - kite-20150630.xml Cover 53 false false All Reports Book All Reports In ''CONDENSED CONSOLIDATED BALANCE SHEETS'', column(s) 2, 4, 5 are contained in other reports, so were removed by flow through suppression. In ''CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value 420848000 and preferred label periodStartLabel, was not shown because there are no facts in a duration starting at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value 42000 and preferred label periodStartLabel, was not shown because there are no facts in a duration starting at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value 420848000 and preferred label periodEndLabel, was not shown because there are no facts in a duration ending at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value -297000 and preferred label periodEndLabel, was not shown because there are no facts in a duration ending at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:SharesOutstanding with value 41855304 and preferred label periodStartLabel, was not shown because there are no facts in a duration starting at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:SharesOutstanding with value 41855304 and preferred label periodEndLabel, was not shown because there are no facts in a duration ending at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value -58004000 and preferred label periodStartLabel, was not shown because there are no facts in a duration starting at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value -297000 and preferred label periodStartLabel, was not shown because there are no facts in a duration starting at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value 42000 and preferred label periodEndLabel, was not shown because there are no facts in a duration ending at 2015-01-01. Change the preferred label role or add facts. In ''CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)'', fact us-gaap:StockholdersEquity with value -58004000 and preferred label periodEndLabel, was not shown because there are no facts in a duration ending at 2015-01-01. Change the preferred label role or add facts. kite-20150630.xml kite-20150630_cal.xml kite-20150630_def.xml kite-20150630_lab.xml kite-20150630_pre.xml kite-20150630.xsd true true